Moderate alcohol consumption does not directly interfere with the efficacy of griseofulvin, but excessive drinking can increase the risk of liver toxicity. Patients with pre-existing liver disease should limit alcohol intake and discuss their consumption with a healthcare professional.
If you remember within 6 hours, take the missed tablet with a fatty meal. If more than 6 hours have passed, skip the missed dose and continue with your regular schedule. Do not double-dose.
No. Griseofulvin is classified as pregnancy category X in the UK because it may cause fetal malformations and should be avoided completely during pregnancy.
Skin infections typically require 4-6 weeks of therapy, while nail infections may need 12 months of continuous treatment to achieve complete cure, due to the slow growth of keratinised tissue.
Yes, but keep the medication in its original, labelled packaging and carry a copy of the prescription. Some countries may require a doctor’s note for prescription medicines, so it is advisable to check entry regulations before travel.
Gresiofulvin tablets are round, film-coated, and marked with the imprint “GF-250”. Other brands may have different shapes, colors, or imprints but contain the same 250 mg dose of griseofulvin.
Yes. Griseofulvin can reduce the plasma concentration of hormonal contraceptives, potentially decreasing their effectiveness. Use a secondary non-hormonal method (e.g., condoms) while on treatment.
A fatty meal enhances the gastrointestinal absorption of griseofulvin, leading to more consistent blood levels. Taking the tablet with a low-fat or fasted state may result in sub-therapeutic exposure.
Certain OTC antacids containing aluminium or magnesium can reduce griseofulvin absorption. Additionally, herbal supplements such as St John’s wort may induce hepatic enzymes and lower drug levels. Inform your pharmacist of all non-prescription products you use.
A mild rash may be a common side effect, but if it spreads, becomes itchy, or is accompanied by fever, seek medical attention promptly. In rare cases, a severe skin reaction may require immediate discontinuation of the drug.
Gresiofulvin is a brand-name medication that contains the active ingredient griseofulvin. It belongs to the antifungal therapeutic class and is supplied as a 250 mg oral pill. In the United Kingdom, griseofulvin is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug works by disrupting fungal cell division, making it useful for treating infections of the skin, hair and nails caused by dermatophyte fungi.
Griseofulvin interferes with the formation of fungal microtubules, which are essential for mitosis (cell division). By binding to fungal tubulin, the drug prevents the proper assembly of the mitotic spindle, halting fungal growth and allowing the host’s immune system to clear the infection.
Griseofulvin is approved in the UK for the treatment of dermatophytoses (tinea infections) affecting the skin, hair or nails. The main indications include:
These uses are supported by MHRA-approved labeling and clinical guidelines for dermatophyte infections.
While Gresiofulvin is licensed for fungal nail infections of the fingernails, many clinicians prescribe it off-label for toenail onychomycosis when other systemic agents (e.g., terbinafine) are unsuitable. Clinical studies have shown that a 12-month course can achieve cure rates of 50-70 % in selected patients.
Regulatory status: Not approved for toenail onychomycosis in the UK. Disclaimer: Off-label use should be supervised by a qualified healthcare professional who can assess benefit-risk balance and monitor for adverse effects.
This article provides educational information about Gresiofulvin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
